HIGHFDA DRUG

Asteria Health Recalls Testosterone Pellets Over Metal Contamination

Asteria Health recalled 7,840 testosterone pellets on January 26, 2026, due to potential metal particulate matter contamination. Consumers must stop using the product immediately and contact healthcare providers for guidance. The recall affects products distributed nationwide in the USA.

Official notice

Source-backed recall notice

No product image was available from the source feed.

Official source
FDA DRUG
Recall date
January 26, 2026
Status
ACTIVE
Severity
8/10

Quick Facts at a Glance

Recall Date
January 26, 2026
Hazard Level
HIGH
Brand
F.H. INVESTMENTS, Inc.
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
1 states
At-Risk Groups
GENERAL

What to Do Now

Use this page like a recall checklist: verify the product first, then act on the official remedy.

Immediate steps

  1. 1Stop using the product until you confirm whether it is included in the recall.
  2. 2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
  3. 3Follow the official remedy from FDA - Drug Safety; save photos, receipts, labels, and correspondence before contacting the company.
  4. 4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.

Check these identifiers

Brand
F.H. INVESTMENTS, Inc.
Product type
Testosterone Pellet
Model numbers
Lot#: 256000105, Exp. 09/19/2026.
Sold at
Multiple Retailers
Where affected
ALL

Recall Timeline

Key dates and source checks for this recall record.

  1. Recall announced

    January 26, 2026

  2. Reported by FDA DRUG

    February 18, 2026

  3. RecallRadar source check

    February 25, 2026

  4. Consumer action

    Use the official remedy and keep documentation.

Hazard Information

Presence of Foreign substance - potential presence of metal particulate matter

What You Should Do

Consumers and healthcare providers should stop using this product immediately. Contact F.H. INVESTMENTS, Inc. (dba Asteria Health) or your healthcare provider for guidance. Notification method: Letter

About This Product

The product is a testosterone pellet used for hormone replacement therapy. Consumers buy it to manage low testosterone levels and related health issues.

Why This Is Dangerous

The contamination risk arises from the potential presence of metal particles, which can cause serious health complications if ingested.

Industry Context

This recall is not part of a broader industry pattern.

Real-World Impact

Consumers must stop using the product immediately, which may interrupt their hormone therapy regimen. This could lead to health implications if alternative therapies are not arranged promptly.

Practical Guidance

How to identify if yours is affected

  1. Check the lot number on the packaging.
  2. Ensure it matches Lot#: 256000105.
  3. Verify the expiration date to confirm the product is affected.

Where to find product info

Look for the lot number and expiration date on the product packaging, usually found on the label or bottom of the box.

What timeline to expect

Expect a refund or replacement process to take approximately 4-6 weeks after contacting the manufacturer.

If the manufacturer is unresponsive

  • Document all correspondence with the manufacturer.
  • Follow up via phone or email if no response is received.
  • Consider filing a complaint with the FDA.

How to prevent similar issues

  • Always check for recalls before purchasing medications.
  • Consult healthcare providers for alternative products when recalls occur.
  • Be aware of product expiration dates and lot numbers.

Documentation advice

Keep records of your purchase, any correspondence regarding the recall, and document the lot number and expiration date.

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

Product Details

The recall involves testosterone pellets containing 200mg of testosterone and 40mcg of triamcinolone acetonide. The affected lot number is 256000105, expiring on September 19, 2026. The product is manufactured by F.H. INVESTMENTS, Inc. and was sold nationwide.

Key Facts

  • Recall date: January 26, 2026
  • Reported date: February 18, 2026
  • Quantity recalled: 7,840 pellets
  • Potential health risk: High
  • Manufacturer: F.H. INVESTMENTS, Inc.

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
8/ 10
Affected Groups
GENERAL
Injury Types
OTHER

Product Classification

Product Details

Model Numbers
Lot#: 256000105
Exp. 09/19/2026.
Affected States
ALL
Report Date
February 18, 2026
Source Agency
FDA - Drug Safety
Recall Status
ACTIVE

Related Recalls

Health & Personal Care
HIGH

Asteria Health Recalls Estradiol Pellets Over Metal Contamination

Asteria Health recalled 24,099 Estradiol, 10 mg pellets on January 26, 2026, due to potential metal particulate contamination. Consumers should stop using the product immediately. The recall affects pellets distributed nationwide in the USA.

F.H. INVESTMENTS, Inc.
Presence of
Read more